1,2,3-triazoles as amide bioisosteres: Discovery of a new class of potent HIV-1 Vif antagonists

Idrees Mohammed, Indrasena Reddy Kummetha, Gatikrushna Singh, Natalia Sharova, Gianluigi Lichinchi, Jason Dang, Mario Stevenson, Tariq M. Rana

Research output: Contribution to journalArticle

53 Scopus citations

Abstract

RN-18 based viral infectivity factor (Vif), Vif antagonists reduce viral infectivity by rescuing APOBEC3G (A3G) expression and enhancing A3G-dependent Vif degradation. Replacement of amide functionality in RN-18 (IC50 = 6 μM) by isosteric heterocycles resulted in the discovery of a 1,2,3-trizole, Id (IC50 = 1.2 μM). We identified several potent HIV-1 inhibitors from a Id based library including 5ax (IC50 = 0.01 μM), 5bx (0.2 μM), 2ey (0.4 μM), 5ey (0.6 μM), and 6bx (0.2 μ M).

Original languageEnglish (US)
Pages (from-to)7677-7682
Number of pages6
JournalJournal of Medicinal Chemistry
Volume59
Issue number16
DOIs
StatePublished - Aug 25 2016

ASJC Scopus subject areas

  • Medicine(all)
  • Molecular Medicine
  • Drug Discovery

Fingerprint Dive into the research topics of '1,2,3-triazoles as amide bioisosteres: Discovery of a new class of potent HIV-1 Vif antagonists'. Together they form a unique fingerprint.

  • Cite this

    Mohammed, I., Kummetha, I. R., Singh, G., Sharova, N., Lichinchi, G., Dang, J., Stevenson, M., & Rana, T. M. (2016). 1,2,3-triazoles as amide bioisosteres: Discovery of a new class of potent HIV-1 Vif antagonists. Journal of Medicinal Chemistry, 59(16), 7677-7682. https://doi.org/10.1021/acs.jmedchem.6b00247